HCV Treatment and Risk of Parkinson ' s Disease in the DAA Era HCV Treatment and Risk of Parkinson ' s Disease in the DAA Era

This study found that T2DM and cirrhosis were risk factors for Parkinson ' s disease and secondary parkinsonism in patients with HCV. Does treatment with DAAs significantly impact the risk?Journal of Viral Hepatitis
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news